Skip to content
lifestyle.pspl.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Medicenna Therapeutics Corp.
Medicenna Therapeutics Appoints Dr. Nageatte Ibrahim as Chief Medical Officer
May 4, 2026
Medicenna to Present Preclinical Data from its First-in-Class Tumor Anchored and Conditionally Activated Anti-PD-1-IL-2 Bifunctional Superkine at the AACR Annual Meeting 2026
April 30, 2026
Medicenna Therapeutics Announces Participation in Upcoming Conferences
February 18, 2026
←
Previous Page
1
2